EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The effect of vaginal tamoxifen on symptoms of anxiety, depression, and health-related quality of life in postmenopausal women with and without breast cancer

Serenay Yazici Sarikaya, Sara Nyback, Birgit Derntl, Lisa Ljungman, Angelica Lindén Hirschberg, Helena Kopp Kallner, Inger Sundström Poromaa, Anna Wikman, Theodora Kunovac Kallak

Maturitas · 2026-08 · 211 · 109010

DOI: 10.1016/j.maturitas.2026.109010 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Maturitas, 2026-08. Verfasst von Serenay Yazici Sarikaya und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, Tübingen Center for Mental Health (TüCMH), 72076, Germany. Hauptthemen laut MEDLINE: Tamoxifen, Anxiety, Postmenopause, Quality of Life. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Cancer Foundation, Percy Falk Foundation for Prostate and Breast Cancer Research, Percy Falk Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TamoxifenAnxietyPostmenopauseQuality of LifeDepressionBreast NeoplasmsHumansFemaleMiddle AgedDouble-Blind MethodAdministration, IntravaginalAgedSurveys and Questionnaires

Stichwörter der Autor:innen

MenopausePainVaginal tamoxifen

Substanzen

Tamoxifen

Autor:innen und Institutionen

  • Department of Psychiatry and Psychotherapy, Tübingen Center for Mental Health (TüCMH), 72076, Germany.
  • Department of Women's and Children's Health, Uppsala University, Uppsala University Hospital, 75185, Uppsala, Sweden.
  • Department of Psychiatry and Psychotherapy, Tübingen Center for Mental Health (TüCMH), 72076, Germany; German Center for Mental Health (DZPG), Partner Site Tübingen, 72076, Germany.
  • Department of Women's and Children's Health, Karolinska Institutet, 17177, Stockholm, Sweden; Department of Gynecology and Reproductive Medicine, Karolinska University Hospital, 14157, Stockholm, Sweden.
  • Department of Clinical Sciences at Danderyd Hospital, Karolinska Institutet, 18288, Stockholm, Sweden; Department of Obstetrics and Gynecology, Danderyd Hospital, 18257, Stockholm, Sweden.
  • Department of Women's and Children's Health, Uppsala University, Uppsala University Hospital, 75185, Uppsala, Sweden. Electronic address: theodora.kunovac_kallak@uu.se.

Förderung

  • Swedish Cancer Foundation
  • Percy Falk Foundation for Prostate and Breast Cancer Research
  • Percy Falk Foundation
  • Magnus Bergvall Foundation
  • Swedish Cancer Society
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Yazici Sarikaya, S., Nyback, S., Derntl, B., Ljungman, L., Hirschberg, A. L., Kopp Kallner, H., Sundström Poromaa, I., Wikman, A., & Kunovac Kallak, T. (2026). The effect of vaginal tamoxifen on symptoms of anxiety, depression, and health-related quality of life in postmenopausal women with and without breast cancer. Maturitas, 211, 109010. https://doi.org/10.1016/j.maturitas.2026.109010

Vancouver

Yazici Sarikaya S, Nyback S, Derntl B, Ljungman L, Hirschberg AL, Kopp Kallner H, et al. The effect of vaginal tamoxifen on symptoms of anxiety, depression, and health-related quality of life in postmenopausal women with and without breast cancer. Maturitas. 2026;211:109010. doi:10.1016/j.maturitas.2026.109010

BibTeX
@article{YaziciSarikaya2026,
  author = {Yazici Sarikaya, Serenay and Nyback, Sara and Derntl, Birgit and Ljungman, Lisa and Hirschberg, Angelica Lindén and Kopp Kallner, Helena and Sundström Poromaa, Inger and Wikman, Anna and Kunovac Kallak, Theodora},
  title = {The effect of vaginal tamoxifen on symptoms of anxiety, depression, and health-related quality of life in postmenopausal women with and without breast cancer},
  journal = {Maturitas},
  year = {2026},
  volume = {211},
  pages = {109010},
  doi = {10.1016/j.maturitas.2026.109010}
}
Kostenlos starten →